脳卒中の高次機能障害に対する薬物療法の試み
スポンサーリンク
概要
- 論文の詳細を見る
Stroke patients often suffer higher brain dysfunction that impairs their quality of life. However, there is little evidence regarding effective medicines to address impaired higher brain function. We examined the effects of treatment with choto-san, an herbal medicine; ropinirole, an anti-Parkinson drug; and cilostazol, an anti-platelet agent on higher brain dysfunction after stroke. After administration of choto-san, patients had significantly improved Mini Mental State Examination and verbal fluency test scores. In event-related brain potentials, P3 latency was significantly shortened, and the amplitude was significantly larger, after choto-san administration. Patients receiving ropinirole therapy showed improved apathy scale and Frontal Assessment Battery scores, used to assess frontal lobe function in patients with frontal lobe ischemic stroke. Compared with the aspirin treatment group, the cilostazol treatment group exhibited significantly improved apathy scale scores. This study suggests that some medicines may be effective in addressing post-stroke higher brain dysfunction. Further study is necessary to characterize these agents.
- 一般社団法人 日本脳卒中学会の論文
一般社団法人 日本脳卒中学会 | 論文
- Two cases with aphasia in the left putaminal damage and one case with visuospatial neglect in the right putaminal damage
- Alterations of plasma von Willebrand factor activity and the influence of anti-platelet drugs in acute cerebral infarction
- Carotid endarterectomy plaques correlation of clinical events and morphology.
- Stenting for stenosis of major cerebrovascular arteries.
- Cerebral infarction following antihypertensive therapy.